Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| METHYL RED 0.01% | METHYL RED 0.01%, UK suppliers of laboratory chemicals wanted |  |
| Methyl Red (C.I. 13020) | 500g Pack Size. Group: Stains & Indicators. Formula: C15H15N3O2. CAS No. 493-52-7. Prepack ID : 27397766-500g. Molecular Weight : 269.3. |  |
| Methyl Red sodium salt | 100g Pack Size. Group: Stains & Indicators. Formula: C15H14N3O2 ·Na. CAS No. 845-10-3. Prepack ID : 12768222-100g. Molecular Weight : 291.28. | |
| 13-O-Desmethyl Tacrolimus | 13-O-Desmethyl Tacrolimus is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (3S,4R,5S,8R,9E,12S,14S,15S,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26-Hexadecahydro-5,16,19-trihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14-methoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-16,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone. CAS No. 139958-51-3. Pack Sizes: 5 mg. Product ID: B1370-386089. Molecular formula: C43H67NO12. Mole weight: 789.99. Custom synthesis is available. Send your inquiries for more information. |  London |
| 1-Butyl-1-methylpiperidinium tetrafluoroborate | 1-Butyl-1-methylpiperidinium tetrafluoroborate is an ionic liquid. It can reduce the vulcanisation onset temperature during the vulcanisation of NBR (acrylonitrile-butadiene elastomer) composites. Group: Pharmaceutical. Alternative Names: 1-butyl-1-methyl piperidinium tetrafluoroborate; [C4MPd]BF4. CAS No. 886439-34-5. Pack Sizes: 25 g. Product ID: B1370-193581. Molecular formula: C10H22BF4N. Mole weight: 243.09. Custom synthesis is available. Send your inquiries for more information. | London |
| (1R, 3R, 4R)- Entecavir | An isomer of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: (1R,3R,4R)-Entecavir ; 2-Amino-9-[(1R,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one. CAS No. 1367369-76-3. Pack Sizes: 1 mg. Product ID: B0249-471009. Molecular formula: C12H15N5O3. Mole weight: 277.29. Custom synthesis is available. Send your inquiries for more information. | London |
| (1R, 3S, 4R)-ent-Entecavir | An isomer of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: 2-Amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-Purin-6-one. CAS No. 188399-46-4. Pack Sizes: 5 mg. Product ID: B0249-471013. Molecular formula: C12H15N5O3. Mole weight: 277.29. Custom synthesis is available. Send your inquiries for more information. | London |
| ((2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide | [[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-phosphonium Bromide is an impurity in the production of Pitavastatin, which is a potent HMG-CoA reductase inhibitor for hypercholesterolemia (elevated cholesterol) and prevention of cardiovascular disease. Group: Pharmaceutical. Alternative Names: Pitavastatin Impurity 44 Bromide; Phosphonium, [[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl]triphenyl-, bromide (1:1). CAS No. 154057-58-6. Pack Sizes: 1mg;1g;10g. Product ID: NP3428. Molecular formula: C37H30BrFNP. Mole weight: 618.52. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-((Z)-5-((E)-2-methyl-3-phenylallylidene)-2,4-dioxothiazolidin-3-yl)acetic acid | An impurity of Epalrestat, a carboxylic acid-based inhibitor of aldose reductase. Group: Pharmaceutical. Alternative Names: 2-[5-((2E)-2-methyl-3-phenylprop-2-enylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]a cetic acid. CAS No. 794510-29-5. Pack Sizes: 10 mg. Product ID: B2694-343860. Molecular formula: C15H13NO4S. Mole weight: 303.3. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Epi-Entecavir | 3-Epi-Entecavir is an impurity of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: Entecavir EP Impurity B; 2-amino-9-[(1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; Entecavir 3-epimer. CAS No. 1367369-77-4. Pack Sizes: 5 mg. Product ID: B0249-260277. Molecular formula: C12H15N5O3. Mole weight: 277.284. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-O-Acetyl-16α-hydroxytrametenolic acid | 3-O-Acetyl-16α-hydroxytrametenolic acid is a triterpene isolated from the sclerotium of Poria cocos(Schw.)Wolf. It has the inhibitory effect on AAPH-induced hemolysis of red blood cells and 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Group: Pharmaceutical. Alternative Names: (2R)-2-[(3S,10S,13R,14R,16R,17R)-3-acetyloxy-16-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid. CAS No. 168293-13-8. Pack Sizes: 5 mg. Product ID: B0005-053911. Molecular formula: C32H50O5. Mole weight: 514.747. Custom synthesis is available. Send your inquiries for more information. | London |
| (3S,5S)-Atorvastatin Acetonide tert-Butyl Ester | (3S,5S)-Atorvastatin Acetonide tert-Butyl Ester is a pharmaceutical compound employed in managing hyperlipidemia and cardiovascular disorders. It is a modified form of atorvastatin, acting as a potent HMG-CoA reductase inhibitor to mitigate cholesterol biosynthesis within hepatic cells. This medication plays a pivotal role in ameliorating lipid profiles and averting atherosclerosis progression. Uses: An intermediate for the preparation of (3s,5s)-atorvastatin. Group: Pharmaceutical. Alternative Names: (4S,6S)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester. CAS No. 472967-95-6. Pack Sizes: 25 mg. Product ID: B2692-117415. Molecular formula: C40H47FN2O5. Mole weight: 654.81. Custom synthesis is available. Send your inquiries for more information. | London |
| 4-Epimer Entecavir | An impurity of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: Entecavir EP Impurity D; (1S,3R,4R)-Entecavir; 2-Amino-9-[(1S,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one; Entecavir 4-epimer; 4'-epi-Entecavir. CAS No. 1367369-80-9. Pack Sizes: 5 mg. Product ID: B0249-471010. Molecular formula: C12H15N5O3. Mole weight: 277.29. Custom synthesis is available. Send your inquiries for more information. | London |
| 4-Methoxyphenyl b-D-glucopyranoside | 4-Methoxyphenyl β-D-glucopyranoside is a naturally occurring compound that has garnered significant attention in the research community due to its potential in suppressing tumor growth and inflammation. Pertinently, animal models have consistently demonstrated its efficacy in inhibiting cancer cell growth and reducing inflammation. Moreover, this compound has shown hopeful prospects in the therapeutic treatment of diabetes and cardiovascular diseases. With its manifold medicinal promises, 4-Methoxyphenyl β-D-glucopyranoside remains a prime target of interest for further research and development. Group: Pharmaceutical. Alternative Names: 4-Methoxyphenyl beta-D-Glucopyranoside; p-Methoxyphenyl b-D-glucoside; 4-Methoxyphenyl b-D-glucopyranoside; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol; methylarbutoside. CAS No. 6032-32-2. Pack Sizes: 5 g. Product ID: B2705-129073. Molecular formula: C13H18O7. Mole weight: 286.28. Custom synthesis is available. Send your inquiries for more information. | London |
| 5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanol | An impurity of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol. CAS No. 142217-78-5. Pack Sizes: 1mg;1g;10g. Product ID: NP3098. Molecular formula: C52H49N5O5. Mole weight: 824. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-Hydroxy Entecavir | A derivative of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: Entecavir EP Impurity C; 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-3H-purine-6,8(7H,9H)-dione. CAS No. 2204369-23-1. Pack Sizes: 5 mg. Product ID: 2204369-23-1. Molecular formula: C12H15N5O4. Mole weight: 293.28. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-Methoxy Entecavir | An impurity of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: 2-Amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-8-methoxy-1H-purin-6(9H)-one; Entecavir EP impurity E. CAS No. 2349444-69-3. Pack Sizes: 5 mg. Product ID: 2349444-69-3. Molecular formula: C13H17N5O4. Mole weight: 307.31. Custom synthesis is available. Send your inquiries for more information. | London |
| A-71623 | A-71623 is a tetrapeptide and acts as a potent CCK1 agonist (IC50 = 3.7 nM) displaying 1200-fold selectivity over the CCK2 receptor. A-71623 is used to suppress appetite and reduce food intake following central or peripheral administration. Group: Pharmaceutical. Alternative Names: A 71623; A-71623; A71623; N-[(1,1-Dimethylethoxy)carbonyl]-L-tryptophyl-N6-[[(2-methylphenyl)amino]carbonyl]-L-lysyl-L-α-aspartyl-Nα-methyl-L-phenylalaninamide. CAS No. 130408-77-4. Pack Sizes: 1mg;1g;10g. Product ID: 130408-77-4. Molecular formula: C44H56N8O9. Mole weight: 840.97. Custom synthesis is available. Send your inquiries for more information. | London |
| A-740003 | A-740003 is potent, selective and competitive P2X7 receptor antagonist. Its IC50 values are 18 and 40 nM for rat and human receptors respectively measured by agonist-stimulated changes in intracellular calcium concentrations. It displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 μM. It reduces nociception in animal models of persistent neuropathic and inflammatory pain. It showed weak or no activity (IC(50) > 10 muM) at other P2 receptors and an array of other neurotransmitter and peptide receptors, ion channels, reuptake sites, and enzymes. It potently blocked agonist-evoked IL-1beta release (IC(50) = 156 nM) and pore formation (IC(50) = 92 nM) in differentiated human THP-1 cells. It produces significant antinociception in animal models of neuropathic and inflammatory pain in vivo. Uses: A-740003 produces significant antinociception in animal models of neuropathic and inflammatory pain in vivo. Group: Pharmaceutical. Alternative Names: A-740003; A 740003; A740003; N-[1-[[(Cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxybenzeneacetamide;N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide. CAS No. 861393-28-4. Pack Sizes: 1mg;1g;10g. Product ID: 861393-28-4. Molecular formula: C26H30N6O3. Mole weight: 474.55. Custom synthesis is available. Send your inquiries for more information. | London |
| A 839977 | A-839977 is a novel and selective P2X7 antagonist. It blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors with IC50 values 20, 42 and 150 nM respectively. It also potently blocked agonist-evoked YO-PRO uptake and IL-1beta release from differentiated human THP-1 cells. It also produced robust antihyperalgesia in the CFA model of inflammatory pain in wild-type mice. It has been exhibited to reduce CFA-induced thermal hyperalgesia in a dose-dependent fashion with the ED50 value of 100μmol/kg. Group: Pharmaceutical. Alternative Names: 1-(2,3-Dichlorophenyl)-N-[[2-[(pyridin-2-yl)oxy]phenyl]methyl]-1H-tetrazol-5-amine. CAS No. 870061-27-1. Pack Sizes: 1mg;1g;10g. Product ID: 870061-27-1. Molecular formula: C19H14Cl2N6O. Mole weight: 413.26. Custom synthesis is available. Send your inquiries for more information. | London |
| A 887826 | A 887826 is a potent voltage-dependent NaV1.8 channel blocker (IC50 = 11 nM in recombinant human NaV1.8 channels). A 887826 is effective on reducing tactile allodynia in neuropathic rat models. Group: Pharmaceutical. Alternative Names: A 887826; A887826; A-887826; 5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-morpholinyl)-3-pyridinyl]methyl-3-pyridine carboxamide. CAS No. 1266212-81-0. Pack Sizes: 1mg;1g;10g. Product ID: 1266212-81-0. Molecular formula: C26H29ClN4O3. Mole weight: 480.99. Custom synthesis is available. Send your inquiries for more information. | London |
| AA 147 | AA 147 is an endoplasmic reticulum (ER) proteostasis regulator. Activates the ATF6 transcriptional program independently of ER stress and/or global UPR activation. Selectively reduces secretion of amyloidogenic transthyretin (TTR) from HepG2 cells. Reduces amyloidogenic immunoglobulin light chain (ALLC) secretion from ALMC-2 cells (EC50 = 1.1 μM). Group: Pharmaceutical. Alternative Names: N-(2-Hydroxy-5-methylphenyl)benzenepropanamide; N-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide. CAS No. 393121-74-9. Pack Sizes: 1mg;1g;10g. Product ID: 393121-74-9. Molecular formula: C16H17NO2. Mole weight: 255.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Acebilustat | Acebilustat, formerly known as ZK322, is an oral anti-inflammatory designed to reduce the production of leukotriene B4 (LTB4). Group: Pharmaceutical. Alternative Names: 4-(((1S,4S)-5-(4-(4-(oxazol-2-yl)phenoxy)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)methyl)benzoic acid; ZK322; ZK-322; ZK 322; CTX-4430; EP-501; CTX4430; EP501; CTX 4430; EP 501; Acebilustat, CAS#943764-99-6. CAS No. 943764-99-6. Pack Sizes: 100 mg. Product ID: B0084-007834. Molecular formula: C29H27N3O4. Mole weight: 481.55. Custom synthesis is available. Send your inquiries for more information. | London |
| AF 353 | AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. It is a highly potent inhibitor of α,β-meATP-evoked intracellular calcium flux in cell lines expressing recombinant rat and human P2X3 and human P2X2/3 channels. It also blocks human P2X2/3 channel function with marginally reduced potency (pIC50 = 7.3). It significantly reduces this parameter in both groups. It also reduces the inter-contractile interval in control but not in SCI rats. Group: Pharmaceutical. Alternative Names: AF353; AF-353; 2,4-Pyrimidinediamine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]-; Ro 4; 5-{[5-iodo-2-(1-Methylethyl)-4-(Methyloxy)phenyl]oxy}-2,4-pyrimidinediamine. CAS No. 865305-30-2. Pack Sizes: 25 mg. Product ID: B2693-459983. Molecular formula: C14H17IN4O2. Mole weight: 400.21. Custom synthesis is available. Send your inquiries for more information. | London |
| α-Hydroxy Flurbiprofen | An impurity of Flurbiprofen. Flurbiprofen is a potent nonsteroidal anti-inflammatory drug (NSAID) belonging to the propionic acid derivative class (like ibuprofen). It exhibits analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis. Group: Pharmaceutical. Alternative Names: Flurbiprofen Impurity C; (2RS)-2-(2-Fluoro[1,1'-biphenyl]-4-yl)-2-hydroxypropanoic acid; (2RS)-2-(2-Fluorobiphenyl-4-yl)-2-hydroxypropanoic Acid; 2-(2-Fluorobiphenyl-4-yl)-2-hydroxypropanoic acid; 2-(2-Fluoro-[1,1'-biphenyl]-4-yl)-2-hydroxypropanoic acid; 2-Fluoro-α-hydroxy-α-methyl[1,1'-biphenyl]-4-acetic acid; 2-(2-Fluoro-4-biphenyl)-2-hydroxypropionic acid; Flurbiprofen EP Impurity C. CAS No. 61466-95-3. Pack Sizes: 250 mg. Product ID: B0965-471758. Molecular formula: C15H13FO3. Mole weight: 260.27. Custom synthesis is available. Send your inquiries for more information. | London |
| ARD-2128 | ARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor degrader. It effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. Group: Pharmaceutical. Alternative Names: ARD2128; ARD 2128; N-[(1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl]-4-[4-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]piperazin-1-yl]benzamide. CAS No. 2222111-87-5. Pack Sizes: 25 mg. Product ID: B1370-380960. Molecular formula: C45H50ClN7O6. Mole weight: 820.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Cyclic Isopropyl Impurity | Atorvastatin Cyclic Isopropyl Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: 4-{6-(4-Fluorophenyl)-7,8-epoxy-6-hydroxy-8a-isopropyl-7-phenyl-8-(phenylcarbamoyl)hexahydro-2H-pyrrolo[2,1-b][1,3]oxazin-2-yl}-3-. hydroxybutanoic acid; Atorvastatin epoxy pyrrolooxazin 6-hydroxy analog; Atorvastatin FXA Impurity; 3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 7-(4-fluorophenyl)hexahydro-β,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-; 7-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid. CAS No. 873950-17-5. Pack Sizes: 10 mg. Product ID: B1370-148308. Molecular formula: C33H35FN2O7. Mole weight: 590.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin EP Impurity D | Atorvastatin EP Impurity D is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide; 3-(4-fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide; Atorvastatin Epoxydione Impurity; 2-Oxiranecarboxamide, 3-(4-fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-; 3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-2-oxiranecarboxamide; USP Atorvastatin Related Impurity D; Atorvastatin EP Impurity D; Atorvastatin USP Related Compound D; Atorvastatin calcium trihydrate impurity D [EP]. CAS No. 148146-51-4. Pack Sizes: 25 mg. Product ID: B2694-466943. Molecular formula: C26H22FNO4. Mole weight: 431.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Epoxy Tetrahydrofuran Impurity | Atorvastatin Epoxy Tetrahydrofuran Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: 4-(4-Fluorophenyl)-2,4-dihydroxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide; Atorvastatin epoxy tetrahydrofuran analog; 4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide; Atorvastatin Photo Degradation Product; 3,6-Dioxabicyclo[3.1.0]hexane-1-carboxamide, 4-(4-fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-; Atorvastatin epoxy THF analog. CAS No. 873950-19-7. Pack Sizes: 1 mg. Product ID: B0190-466978. Molecular formula: C26H24FNO5. Mole weight: 449.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Ethyl Ester | Atorvastatin Ethyl Ester is the impurity of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Group: Pharmaceutical. Alternative Names: (3R,5R)-Ethyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, ethyl ester, (βR,δR)-; Ethyl (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate; Ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate. CAS No. 1146977-93-6. Pack Sizes: 25 mg. Product ID: B2694-466959. Molecular formula: C35H39FN2O5. Mole weight: 586.71. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Methyl Ester | Atorvastatin Methyl Ester is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Methyl Ester; (3R,5R)-Methyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbaMoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, methyl ester, (βR,δR)-; Methyl (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate. CAS No. 345891-62-5. Pack Sizes: 50 mg. Product ID: B0190-466944. Molecular formula: C34H37FN2O5. Mole weight: 572.68. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide | Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide is a prominent compound in the research of dyslipidemia and associated cardiovascular disorders. Its efficacious mechanism of action lies in its tremendous capacity to inhibit HMG-CoA reductase, a pivotal enzyme profoundly engaged in the intricate process of cholesterol biosynthesis. Uses: Atorvastatin (a791750) impurity. Group: Pharmaceutical. Alternative Names: (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-heptanoic Acid Calcium Salt. CAS No. 1105067-87-5. Pack Sizes: 10 mg. Product ID: B0190-258830. Molecular formula: C40H48FN3O8?0.5Ca. Mole weight: 736.86. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound A | Atorvastatin USP Related Compound A is an impurity in the synthesis of Atorvastatin, which is a competitive HMG-CoA reductase inhibitor. Atorvastatin is a lipid-lowering medication of the statin class. Atorvastatin suppresses the production of cholesterol and prevents some cardiovascular diseases. Group: Pharmaceutical. Alternative Names: Calcium (3R,5R)-7-[2-isopropyl-4,5-diphenyl-3-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin Desfluoro impurity; (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicacid, calcium salt; USP Atorvastatin Related Compound A; Defluoro Atorvastatin Calcium Salt; Atorvastatin Related Compound A; Calcium (3R,5R)-3,5-dihydroxy-7-(2-isopropyl-4,5-diphenyl-3-(phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate; 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-; Calcium (βR,δR)-β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2). CAS No. 433289-83-9. Pack Sizes: 100 mg. Product ID: B0190-168852. Molecular formula: C66H70CaN4O10. Mole weight: 1119.38. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound C | Atorvastatin USP Related Compound C is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: USP Atorvastatin Related Compound C; Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin Difluoro impurity; (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; (βR,δR)-2,3-Bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-; Atorvastatin Related Compound C; Difluoro Atorvastatin Calcium Salt. CAS No. 693793-53-2. Pack Sizes: 20 mg. Product ID: B2694-168854. Molecular formula: C66H66CaF4N4O10. Mole weight: 1191.32. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound E | Atorvastatin USP Related Compound E is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: USP Atorvastatin Related Compound E; Calcium (3S,5S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin 3S,5S Enantiomer; (3S,5S)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; Atorvastatin Related Compound E; (3S,5S)-Atorvastatin Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βS,δS)-. CAS No. 1105067-88-6. Pack Sizes: 5 mg. Product ID: B0190-466957. Molecular formula: C66H68CaF2N4O10. Mole weight: 1155.38. Custom synthesis is available. Send your inquiries for more information. | London |
| Atractylenolide I | Atractylenolide I is a sesquiterpenoid found in the rhizome of Atractylodes macrocephala. Atractylenolide I ameliorates sepsis syndrome by reduction of pro-inflammatory cytokines and LPS, and provides an improvement in liver and kidney functions. Uses: Anti-inflammatory. Group: Pharmaceutical. Alternative Names: ATRACTYLENOLIDE-1; (4aS,8aS)-4a,5,6,7,8,8a-Hexahydro-3,8a-dimethyl-5-methylenenaphtho[2,3-b]furan-2(4H)-one; 3,8aβ-Dimethyl-5-methylene-2,4,4aα,5,6,7,8,8a-octahydronaphtho[2,3-b]furan-2-one; Eudesma-4(15),7(11),8-trien-12-olide; 8,9-Dehydroasterolide. CAS No. 73069-13-3. Pack Sizes: 10 mg. Product ID: NP6004. Molecular formula: C15H18O2. Mole weight: 230.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Atranorin | Atranorin, which can be found in the herbs of Parmelia tinctorum Despr, has a relevant redox-active action, acting as a pro-oxidant or antioxidant agent depending on the radical. Also, it will exert cytoprotective effects on cells under oxidative stress induced by H(2)O(2). It was found to be more efficient at equitoxic doses and correlated more strongly with an increased number of floating cells or a higher apoptotic index. It also exhibited significant anti-inflammatory activity in the acute model of inflammation (leukocyte migration to the peritoneal cavity), carrageenan- and arachidonic acid-induced hind paw edema in rats. Besides, Atranorin exhibited a dose-dependent antioxidant activity in vitro, as assessed by total radical-trapping antioxidant parameter and total antioxidant reactivity assays. Uses: Antinociceptive/antiinflammatory/antibacterial. Group: Pharmaceutical. Alternative Names: Atranoric acid; Atranorine; Parmelin; Usnarin; Benzoic acid, 3-formyl-2,4-dihydroxy-6-methyl-, 3-hydroxy-4-(methoxycarbonyl)-2,5-dimethylphenyl ester. CAS No. 479-20-9. Pack Sizes: 100 mg. Product ID: NP4582. Molecular formula: C19H18O8. Mole weight: 374.34. Custom synthesis is available. Send your inquiries for more information. | London |
| AZ5104 | AZ5104 is a potent EGFR inhibitor and a derivative of AZD 9291. AZ5104 exhibits reduced selectivity against wild-type EGFR but five-fold potentcy compared to AZD 9291. Group: Pharmaceutical. Alternative Names: AZ-5104; AZ 5104; N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide. CAS No. 1421373-98-9. Pack Sizes: 25 mg. Product ID: B0084-470856. Molecular formula: C27H31N7O2. Mole weight: 485.592. Custom synthesis is available. Send your inquiries for more information. | London |
| Azacytidine-[13C5] | Labelled Azacytidine, produced by the strain of Streptoverticillium ladakanus var. ladakanus UC-2654. Azacitidine (Vidaza) is a chemotherapy drug used to treat conditions that affect the blood and the bone marrow, called myelodysplastic syndromes (MDS). It may also be used to treat other cancers, such as acute myeloid leukaemia (AML) or chronic myelomonocytic leukaemia (CMML). It reduces hypermethylation associated with certain diseases, including myelodysplastic syndromes (IC50s = 2.4 and 2.6 μM for in vitro anti-myeloma activity) and cancer (IC50s ~ 0.4 μM for inhibiting proliferation of various cancer cell lines). It can also act as a demethylating agent by inhibiting DNA methyltransferase. Group: Pharmaceutical. Alternative Names: 4-Amino-1-[3,4-dihydroxy-5-(hydroxy(113C)methyl)(2,3,4,5-13C4)oxolan-2-yl]-1,3,5-triazin-2-one. Pack Sizes: 1 mg. Product ID: BLP-003371. Molecular formula: C3[13C]5H12N4O5. Mole weight: 249.17. Custom synthesis is available. Send your inquiries for more information. | London |
| Betahistine | Betahistine is a H1 receptor agonist, which serves as a vasodilator. It is used in Meniere disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. It is an antivertigo drug first used for treating vertigo. It is also commonly used for patients with balance disorders. It is believed to act by reducing the asymmetrical functioning of sensory vestibular organs as well as by increasing vestibulocochlear blood flow. It also acts as a histamine H3-receptor antagonist which causes an increased output of histamine from histaminergic nerve endings which can further increase the direct H1-agonist activity. It has been listed. Uses: Betahistine is used in meniere disease and in vascular headaches. it is an antivertigo drug first used for treating vertigo. it is also commonly used for patients with balance disorders. Group: Pharmaceutical. Alternative Names: N-methyl-2-pyridin-2-ylethanamine. CAS No. 5638-76-6. Pack Sizes: 2 g. Product ID: B0084-329466. Molecular formula: C8H12N2. Mole weight: 136.19. Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-D-FMK | BOC-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-α (TNFα). It has been found to reduce the activation of nuclear factor kappa light chain enhancer of activated B cells (NF-kB), suppress the phosphorylation of subunit nuclear factor kappa light polypeptide gene enhancer in B cells inhibitor α (IkBα) and inhibit TNF-induced expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1). Moreover, it has also effectively attenuated the hepatocyte apoptosis in bile duct-ligated rats potentially improving the survival rates. Uses: Caspase inhibitors. Group: Pharmaceutical. Alternative Names: Boc-Asp(OMe)-fluoromethyl ketone; Caspase Inhibitor 3; N-Boc-L-aspartic acid 4-methyl ester fluoromethyl ketone; BAF; Boc-D-Fluoromethyl Ketone; Boc-D(OMe)-FMK; 3S-[[(1,1-dimethylethoxy)carbonyl]amino]-5-fluoro-4-oxo-pentanoic acid, methyl ester; Caspase Inhibitor III. CAS No. 187389-53-3. Pack Sizes: 100 mg. Product ID: BAT-010386. Molecular formula: C11H18FNO5. Mole weight: 263.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Butafosfan | Butafosfan, a component of Catosal, is licensed for the treatment of metabolic disorders or as a tonic in swine. It reduces the stress-induced cortisol (C696302, d4 labelled) response after mixing of unfamiliar pigs. It can also increase milk production in Holstein cows in combination with cyanocobalamin. Group: Pharmaceutical. Alternative Names: P-[1-(Butylamino)-1-methylethyl]-phosphinic Acid; [1-(Butylamino)-1-methylethyl]-phosphinic Acid; 1-(Butylamino)-1-methylethylphosphonous Acid; Butaphosphan. CAS No. 17316-67-5. Pack Sizes: 1mg;1g;10g. Product ID: 17316-67-5. Molecular formula: C7H18NO2P. Mole weight: 179.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Byakangelicin | Byakangelicin is an effective inhibitor of sex hormones and affects the catabolism of endogenous hormones. It directly affects the cytochrome P450 isoform (CY) P3A4 in human hepatocytes. It is an inhibitor of aldose reductase used in the treatment of diabetic cataracts. Byakangelicin is a natural coumarin compound found in Murraya koenigii, Triphasia trifoliata, and other organisms. Group: Pharmaceutical. Alternative Names: 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy-; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-, (R)-; 9-[(2R)-2,3-Dihydroxy-3-methylbutoxy]-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; Biacangelicin; (+)-Byakangelicin; 5-Methoxy-8-(2,3-dihydroxy-3-methylbutoxy)psoralene; Bjacangelicin; Bjakangelicin; Byankagelicine. CAS No. 482-25-7. Pack Sizes: 10 mg. Product ID: NP1139. Molecular formula: C17H18O7. Mole weight: 334.32. Custom synthesis is available. Send your inquiries for more information. | London |
| Calcium N5-methyltetrahydrofolate | Calcium N5-methyltetrahydrofolate is a metabolite of folic acid. It was shown to inhibit photosensitization reactions and strand breaks in DNA, and reduce total serum homocysteine level in orthotopic liver transplant recipients. Group: Pharmaceutical. Alternative Names: Calcium methyltetrahydrofolate; NSC 173328; NSC-173328; NSC173328. CAS No. 26560-38-3. Pack Sizes: 1 g. Product ID: B0084-177400. Molecular formula: C20H23CaN7O6. Mole weight: 497.52. Custom synthesis is available. Send your inquiries for more information. | London |
| CAL Fluor Red 610 CE Phosphoramidite | CAL Fluor Red 610 CE Phosphoramidite, a highly sensitive and reliable fluorescent dye, is commonly applied for the real-time PCR detection and quantification of nucleic acid targets relevant to the diagnosis and management of various diseases, including cancer and viral infections, rendering it an indispensable asset to the biomedical research community and clinical diagnostic industry. Group: Pharmaceutical. Alternative Names: 1H,5H,11H,15H-Xantheno[2,3,4-ij:5,6,7-i'j']diquinolizin-18-ium, 9-[2-[[4-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]-1-piperidinyl]carbonyl]phenyl]-2,3,6,7,12,13,16,17-octahydro-, hexafluorophosphate(1-) (1:1); CAL Fluor Red 610 Amidite; CAL Fluor Red 610; CFR 610 Amidite. CAS No. 861143-34-2. Pack Sizes: 250 mg. Product ID: B1370-362811. Molecular formula: C46H57N5O4P2F6P. Mole weight: 919.93. Custom synthesis is available. Send your inquiries for more information. | London |
| Canagliflozin | Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. Group: Pharmaceutical. Alternative Names: D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-; JNJ-24831754; TA-7284; JNJ 24831754; TA 7284; JNJ24831754; TA7284; (1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thien-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene; Invokana; JNJ 24831754ZAE; JNJ 28431754AAA. CAS No. 842133-18-0. Pack Sizes: 1 g. Product ID: NP3628. Molecular formula: C24H25FO5S. Mole weight: 444.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Cangrelor tetrasodium | Cangrelor tetrasodium is an ATP analogue and acts as a reversible antagonist of P2Y12 receptor. Pretreatment with cangrelor significantly reduces blood clotting induced by ADP in a mouse model of pulmonary thromboembolism. Group: Pharmaceutical. Alternative Names: Cangrelor Tetrasodium; AR-C69931MX; AR C69931MX; ARC69931MX; N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)-betagamma-dichloromethylene-ATP tetrasodium salt. CAS No. 163706-36-3. Pack Sizes: 10 mg. Product ID: B0084-468043. Molecular formula: C17H21Cl2F3N5Na4O12P3S2. Mole weight: 864.274. Custom synthesis is available. Send your inquiries for more information. | London |
| CBS9106 | CBS9106, also known as BMS-566419, is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity. CRM1 plays an important role in the nuclear export of cargo proteins bearing nuclear exporting signal sequences. CBS9106 inhibits CRM1-dependent nuclear export, causing arrest of the cell cycle and inducing apoptosis in a time- and dose-dependent manner for a broad spectrum of cancer cells, including multiple myeloma cells. CBS9106 reduces CRM1 protein levels significantly without affecting CRM1 mRNA expression. Oral administration of CBS9106 significantly suppresses tumor growth and prolongs survival in mice bearing tumor xenograft without a significant loss in body weight. A reduced level of CRM1 protein is also observed in tumor xenografts isolated from mice treated with CBS9106. Taken together, these results indicate that CBS9106 is a novel reversible CRM1 inhibitor and a promising clinical candidate. Group: Pharmaceutical. Alternative Names: SL-801; SL801; SL 801; CBS-9106; CBS 9106; BMS-566419; BMS566419; BMS 566419; 1H-Pyrrole-2,5-dione, 1-[[6-chloro-5-(trifluoromethyl)-2-pyridinyl]amino]-3-[(3,3-dimethylbutoxy)methyl]-4-methyl-. CAS No. 1076235-04-5. Pack Sizes: 10 mg. Product ID: B1370-462313. Molecular formula: C18H21ClF3N3O3. Mole weight: 419.83. Custom synthesis is available. Send your inquiries for more information. | London |
| Chlorphenamine EP Impurity C | An impurity of Chlorpheniramine, which inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxylase mRNA translation by 50%-70% at the 250 μM. Group: Pharmaceutical. Alternative Names: N-Desmethylchlorpheniramine; monodesmethylchlorpheniramine; N-Methyl-3-(4-chlorophenyl)-3-(2-pyridyl)propan-1-amine; γ-(4-Chlorophenyl)-N-methyl-2-pyridinepropanamine. CAS No. 20619-12-9. Pack Sizes: 25 mg. Product ID: B1370-421154. Molecular formula: C15H17ClN2. Mole weight: 260.76. Custom synthesis is available. Send your inquiries for more information. | London |
| Choline Fenofibrate | Choline fenofibrate is a hydrophilic formulation of fenofibric acid that acts primarily by activating peroxisome proliferator-activated receptor alpha (PPARα). This nuclear receptor modulates the transcription of genes involved in lipid metabolism. Once activated, PPARα increases the expression of lipoprotein lipase (LPL), which hydrolyzes triglycerides in lipoproteins, thereby reducing plasma triglyceride levels. It also decreases the production of apolipoprotein C-III (ApoC-III), an inhibitor of LPL, further promoting triglyceride breakdown. Additionally, choline fenofibrate stimulates the synthesis of high-density lipoprotein cholesterol (HDL-C) by upregulating the expression of apolipoprotein A-I (ApoA-I) and apolipoprotein A-II (ApoA-II). This multifaceted mechanism helps in managing mixed dyslipidemia by lowering triglycerides and increasing HDL-C levels. Group: Pharmaceutical. Alternative Names: Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate (1:1); Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (1:1); ABT 335; FNFC; Trilipix. CAS No. 856676-23-8. Pack Sizes: 5 g. Product ID: B0084-259938. Molecular formula: C22H28ClNO5. Mole weight: 421.91. Custom synthesis is available. Send your inquiries for more information. | London |
| Clevidipine butyrate | Clevidipine Butyrate is a dihydropyridine calcium channel blocker, uses as an agent for the reduction of blood pressure. Group: Pharmaceutical. Alternative Names: 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid 3-Methyl 5-[(1-Oxobutoxy)methyl] Ester; Clevelox; Cleviprex; H 324/38; rac-Clevidipine. CAS No. 167221-71-8. Pack Sizes: 250 mg. Product ID: NP3328. Molecular formula: C21H23Cl2NO6. Mole weight: 456.32. Custom synthesis is available. Send your inquiries for more information. | London |
| Clobetasol | Clobetasol is a highly potent topical corticosteroid used to treat various skin conditions such as eczema and psoriasis. It works by reducing inflammation, redness, itching, and rashes. Clobetasol has strong anti-inflammatory, antipruritic, and vasoconstrictive properties. Uses: Anti-inflammatory agents; glucocorticoids. Group: Pharmaceutical. Alternative Names: Clobetasol Propionate EP Impurity G; (11β,16β)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione; 21-Chloro-9-fluoro-11β,17-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione; Clobetasol Propionate Impurity G; Dovate; Clobecort Amex; (8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one. CAS No. 25122-41-2. Pack Sizes: 20 mg. Product ID: B1726-064125. Molecular formula: C22H28ClFO4. Mole weight: 410.92. Custom synthesis is available. Send your inquiries for more information. | London |
| Clodronate disodium tetrahydrate | Clodronate is a non-nitrogenous bisphosphonate that can bind to bone to reduce the bone resorption. It is used as an anti-osteoporotic drug for the prevention of osteoporosis in post-menopausal women and men. Uses: The treatment of osteoporosis. Group: Pharmaceutical. Alternative Names: (Dichloromethylene)bisphosphonic Acid Disodium Salt Tetrahydrate; Sodium clodronate hydrate; Disodium [dichloro(phosphonato)methyl]phosphonic acid tetrahydrate. CAS No. 88416-50-6. Pack Sizes: 10 g. Product ID: B0084-099837. Molecular formula: CH10Cl2Na2O10P2. Mole weight: 360.908. Custom synthesis is available. Send your inquiries for more information. | London |
| Clopidogrel USP Related Compound C | An impurity of Clopidogrel, an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. Group: Pharmaceutical. Alternative Names: USP Clopidogrel Related Compound C; Methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate; Clopidogrel Bisulfate Related Compound C; Clopidogrel RC C; Clopidogrel Related Compound C; Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αR)-, sulfate (1:1); (R)-(-)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate; (R)-(-)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate; (R)-Clopidogrel bisulfate; (R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; SR 25989C; R-(-)-Clopidogrel Hydrogen Sulfate. CAS No. 120202-71-3. Pack Sizes: 50 mg. Product ID: B0153-469249. Molecular formula: C16H16ClNO2S.H2O4S. Mole weight: 419.9. Custom synthesis is available. Send your inquiries for more information. | London |
| Coenzyme Q9 | Coenzyme Q9 is a co-enzyme that is lipid solumbe compononet of cell membranes. It is useful in electron and proton transport of liposome systems. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis. Group: Pharmaceutical. Alternative Names: 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-; coenzyme Q9; CoQ9; ubiquinone 9; ubiquinone 9, (Z,Z,Z,Z,Z,E,E,E)-isomer; ubiquinone Q-9; ubiquinone-9. CAS No. 303-97-9. Pack Sizes: 50 mg. Product ID: B2699-305013. Molecular formula: C54H82O4. Mole weight: 795.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Cynaropikrin | Cynaropikrin, a polyphenolic compound, is a sesquiterpene lactone in C. scolymus. Cynaropikrin is the bitter principle in artichoke and is, therefore, an important compound in the chemical profiling of the plant. Cynara scolymus L. (Asteraceae), commonly found in southern Europe and the USA, is cultivated as a vegetable and medicinal plant artichoke leaves are traditionally used for treatment of bile and liver diseases. Pharmacological studies have shown that extracts of the plant significantly increase choleresis (C. scolymus is used for treatment of dyspeptic syndrome) and reduce blood cholesterol, mainly because of inhibition of hepatocellular de novo cholesterol biosynthesis. Group: Pharmaceutical. Alternative Names: 2-Propenoic acid, 2-(hydroxymethyl)-, dodecahydro-8-hydroxy-3,6,9-tris(methylene)-2-oxoazuleno[4,5-b]furan-4-yl ester, [3aR-(3aα,4α,6aα,8β,9aα,9bβ)]-; Cynaropicrin (6CI); Azuleno[4,5-b]furan, 2-propenoic acid deriv. CAS No. 35730-78-0. Pack Sizes: 10 mg. Product ID: B0005-479861. Molecular formula: C19H22O6. Mole weight: 346.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Demecarium bromide | Demecarium is a parasympathomimetic that acts as an acetylcholinesterase inhibitor. It is one of several topical (applied directly to the affected area) medications used to reduce elevated intraocular pressure (IOP) associated with primary glaucoma in cats, dogs, and other animals. Uses: Cholinesterase inhibitors; miotics. Group: Pharmaceutical. Alternative Names: 3,3'-[1,10-decanediylbis[(methylimino)carbonyloxy]]bis[N,N,N-trimethylbenzenaminium Bromide; (m-Hydroxyphenyl)trimethylammonium Bromide Decamethylenebis[methylcarbamate]; (m-hydroxyphenyl)trimethylammonium Bromide Decamethylenebis[methylcarbamate]; Demekarium Bromide; Demekastigmine Bromide; Frumtosnil; Humorsol. CAS No. 56-94-0. Pack Sizes: 500 mg. Product ID: B0084-071868. Molecular formula: White Solid. Mole weight: 716.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Des(2-methylbutyryl) Lovastatin Hydroxy Acid Sodium Salt | An impurity of Lovastatin. Lovastatin is an HMG CoA reductase inhibitor used to treat high blood cholesterol. Group: Pharmaceutical. Alternative Names: 3,5-Dihydroxy-7-(8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl)heptenoate Acid Sodium Salt; [1S-[1α(βS*,δS*),2β,6β,8β,8aα]]-1,2,6,7,8,8a-hexahydro-β,δ,8-trihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Monosodium Salt. CAS No. 132294-94-1. Pack Sizes: 10 mg. Product ID: B2694-255494. Molecular formula: C19H29O5Na. Mole weight: 360.42. Custom synthesis is available. Send your inquiries for more information. | London |
| Desoximetasone | Desoximetasone is a synthetic corticosteroid, a class of primarily synthetic steroids used as anti-inflammatory and anti-pruritic agents, which is used for the relief of various skin conditions and helps to reduce redness, itching, and irritation. Group: Pharmaceutical. Alternative Names: A 41-304; A 41304; A-41-304; Dexamethasone EP Impurity F; 17-Deoxydexamethasone; Desoximetasona; Desoximetasonum; Desoxymethasone; Flubason; baril; R 2113; Stiedex; Topicort; Topicort LP; Topisolon; 9-Fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione. CAS No. 382-67-2. Pack Sizes: 100 mg. Product ID: B2694-067642. Molecular formula: C22H29FO4. Mole weight: 376.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Diroximel Fumarate | Diroximel Fumarate is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body. It reduces the progressive damage to nerve cells via activating the Nrf2 pathway. It also acts as a NF-kappa B inhibitor. Group: Pharmaceutical. Alternative Names: ALKS8700; ALKS 8700; ALKS-8700; 2-(2,5-Dioxopyrrolidin-1-yl)ethyl methyl fumarate; 1-[2-(2,5-Dioxo-1-pyrrolidinyl)ethyl] 4-methyl (2E)-2-butenedioate; 2-Butenedioic acid (2E)-, 1-[2-(2,5-dioxo-1-pyrrolidinyl)ethyl] 4-methyl ester. CAS No. 1577222-14-0. Pack Sizes: 100 mg. Product ID: B0084-284754. Molecular formula: C11H13NO6. Mole weight: 255.22. Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil | Donepezil, also called Aricept, a centrally acting reversible acetyl cholinesterase inhibitor that the FDA has also approved for the treatment of moderate to severe Alzheimer's disease. It readily crosses the blood-brain barrier to reduce the breakdown of acetylcholine by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. Group: Pharmaceutical. Alternative Names: 2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one; (±)-E 2020; 1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine; Neuripezil; Tonizep; 2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; Aricept; HSDB 7743; HSDB7743; HSDB-7743; 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride; 2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; Eranz; Aricept ODT; donepezilo; donepezilum; CHEMBL502; donepezil hydrochloride; donepezilium oxalate trihydrate; E 2020; E-2020; E2020; 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one; (RS)-2-[(1-BENZYL-PIPERIDIN-4-YL)METHYL]-5,6-DIMETHOXYINDAN-1-ONE. CAS No. 120014-06-4. Pack Sizes: 50 g. Product ID: B2692-082304. Molecular formula: C24H29NO3. Mole weight: 379.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Edaravone Trimer | Edaravone Trimer is an impurity of Edaravone. Edaravone is a novel potent free radical scavenger that reduces reactive oxygen species, inhibits apoptosis, and blocks nonenzymatic peroxidation and lipoxygenase activity. Group: Pharmaceutical. Alternative Names: 5,?5',?5''-trimethyl-2,?2',?2''-triphenyl-[4,?4':4',?4''-Ter-4H-pyrazole]?-3,?3',?3''(2H,?2'H,?2''H)?-trione; 4,4-bis(3-methyl-5-oxo-1-phenyl(2-pyrazolin-4-yl))-3-methyl-1-phenyl-2-pyrazol in-5-one; 2-Phenyl-5-methyl-4,4-bis(2-phenyl-3-oxo-5-methyl-3,4-dihydro-2H-pyrazole-4-yl)-3,4-dihydro-2H-pyrazole-3-one. CAS No. 68195-63-1. Pack Sizes: 50 mg. Product ID: B1370-105475. Molecular formula: C30H26N6O3. Mole weight: 518.58. Custom synthesis is available. Send your inquiries for more information. | London |
| ELQ-300 | ELQ-300 is a potent and orally bioavailable antimalarial agent, and it is a novel inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (complex III in the electron transport chain). Group: Pharmaceutical. Alternative Names: ELQ300; ELQ 300; 6-Chloro-7-methoxy-2-methyl-3-(4-(4-(trifluoromethoxy)phenoxy)phenyl)quinolin-4(1H)-one. CAS No. 1354745-52-0. Pack Sizes: 50 mg. Product ID: B1370-334059. Molecular formula: C24H17ClF3NO4. Mole weight: 475.84. Custom synthesis is available. Send your inquiries for more information. | London |
| Eprinomectin B1b | It is a semi-synthetic analogue of avermectin B1b prepared by oxidation of the 4''-hydroxy moiety and reductive amination followed by acetylation. It is the minor component (<10%) of the commercial product for endo- and exo-parasite control, eprinomectin. It is a potent insecticide and acaricide. Group: Pharmaceutical. Alternative Names: (4''R)-4''-(Acetylamino)-5-O-demethyl-25-de(1-methylpropyl)-4''-deoxy-25-(1-methylethyl)avermectin A1a; Eprinomectin component B1b. CAS No. 133305-89-2. Pack Sizes: 1mg;1g;10g. Product ID: BBF-04245. Molecular formula: C49H73NO14. Mole weight: 900.1. Custom synthesis is available. Send your inquiries for more information. | London |
| Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate | An impurity of Febuxostat. Febuxostat is an antihyperuricemic nonpurine inhibitor of both the oxidized and reduced forms of xanthine oxidase. Group: Pharmaceutical. Alternative Names: Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate. CAS No. 161798-02-3. Pack Sizes: 1mg;1g;10g. Product ID: NP3334. Molecular formula: C14H12N2O3S. Mole weight: 288.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | An impurity of Febuxostat. Febuxostat is an antihyperuricemic nonpurine inhibitor of both the oxidized and reduced forms of xanthine oxidase. Group: Pharmaceutical. Alternative Names: Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate. CAS No. 160844-75-7. Pack Sizes: 1mg;1g;10g. Product ID: NP3333. Molecular formula: C18H20N2O3S. Mole weight: 344.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | An impurity of Febuxostat. Febuxostat is an antihyperuricemic nonpurine inhibitor of both the oxidized and reduced forms of xanthine oxidase. Group: Pharmaceutical. Alternative Names: Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate. CAS No. 161798-01-2. Pack Sizes: 1mg;1g;10g. Product ID: NP3332. Molecular formula: C14H13NO4S. Mole weight: 291.33. Custom synthesis is available. Send your inquiries for more information. | London |
| ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylate | ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylate is an impurity of Febuxostat. Febuxostat is an antihyperuricemic nonpurine inhibitor of both the oxidized and reduced forms of xanthine oxidase. Group: Pharmaceutical. Alternative Names: ethyl 2-(3-formyl-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylate. CAS No. 2230270-05-8. Pack Sizes: 25 mg. Product ID: B1370-377731. Molecular formula: C18H20N2O3S. Mole weight: 344.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Evofosfamide | Evofosfamide is a hypoxia-activated prodrug consisting of a 2-nitroimidazole phosphoramidate conjugate with potential antineoplastic activity. The 2-nitroimidazole moiety of hypoxia-activated prodrug TH-302 acts as a hypoxic trigger, releasing the DNA-alkylating dibromo isophosphoramide mustard moiety within hypoxic regions of tumors. Normoxic tissues may be spared due to the hypoxia-specific activity of this agent, potentially reducing systemic toxicity. Group: Pharmaceutical. Alternative Names: TH-302; TH 302; TH302; 2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine. CAS No. 918633-87-1. Pack Sizes: 50 mg. Product ID: B0084-460516. Molecular formula: C9H16Br2N5O4P. Mole weight: 449.04. Custom synthesis is available. Send your inquiries for more information. | London |
| Febuxostat Amide Impurity | An impurity of Febuxostat. Febuxostat is an antihyperuricemic nonpurine inhibitor of both the oxidized and reduced forms of xanthine oxidase. Group: Pharmaceutical. Alternative Names: 2-[3-(Aminocarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid. CAS No. 1239233-86-3. Pack Sizes: 25 mg. Product ID: B0024-471481. Molecular formula: C16H18N2O4S. Mole weight: 334.4. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
